| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Hypotension | 2 | 2017 | 392 | 1.01 | Why? |
| Ultrasonography | 8 | 2021 | 4409 | 0.79 | Why? |
| Polyendocrinopathies, Autoimmune | 1 | 2020 | 129 | 0.75 | Why? |
| Dilatation | 1 | 2017 | 181 | 0.62 | Why? |
| Arteriovenous Malformations | 1 | 2016 | 33 | 0.62 | Why? |
| Telangiectasia, Hereditary Hemorrhagic | 1 | 2016 | 51 | 0.61 | Why? |
| Esophagus | 1 | 2017 | 139 | 0.60 | Why? |
| Pulmonary Gas Exchange | 1 | 2018 | 414 | 0.60 | Why? |
| Pleura | 1 | 2017 | 178 | 0.59 | Why? |
| Hemofiltration | 1 | 2016 | 155 | 0.57 | Why? |
| Pulmonary Veins | 1 | 2016 | 146 | 0.56 | Why? |
| Cardiac Tamponade | 1 | 2017 | 165 | 0.55 | Why? |
| Psychomotor Agitation | 1 | 2016 | 208 | 0.54 | Why? |
| Pulmonary Alveoli | 1 | 2018 | 867 | 0.51 | Why? |
| Nitric Oxide | 1 | 2020 | 769 | 0.51 | Why? |
| Hematologic Diseases | 1 | 2019 | 614 | 0.46 | Why? |
| Echocardiography | 3 | 2020 | 3661 | 0.42 | Why? |
| Extracorporeal Membrane Oxygenation | 4 | 2020 | 5002 | 0.41 | Why? |
| Heart Ventricles | 1 | 2019 | 1139 | 0.40 | Why? |
| Pulmonary Artery | 1 | 2016 | 803 | 0.38 | Why? |
| Heart Arrest | 1 | 2019 | 1239 | 0.35 | Why? |
| Venous Thromboembolism | 3 | 2020 | 4273 | 0.34 | Why? |
| Intensive Care Units | 10 | 2021 | 29594 | 0.30 | Why? |
| Health Services Needs and Demand | 1 | 2020 | 3419 | 0.29 | Why? |
| Respiratory Insufficiency | 4 | 2021 | 7301 | 0.28 | Why? |
| Vascular Surgical Procedures | 3 | 2021 | 882 | 0.26 | Why? |
| Italy | 15 | 2021 | 38444 | 0.25 | Why? |
| Dyspnea | 1 | 2016 | 3847 | 0.24 | Why? |
| Lung | 9 | 2021 | 31049 | 0.24 | Why? |
| Critical Care | 3 | 2020 | 14081 | 0.23 | Why? |
| Arteries | 2 | 2021 | 283 | 0.23 | Why? |
| Occupational Exposure | 1 | 2020 | 4742 | 0.22 | Why? |
| Pneumonia, Viral | 13 | 2020 | 243684 | 0.21 | Why? |
| Coronavirus Infections | 13 | 2020 | 253789 | 0.21 | Why? |
| Heart Failure | 4 | 2020 | 6638 | 0.21 | Why? |
| Organization and Administration | 1 | 2020 | 93 | 0.21 | Why? |
| Pneumonia | 1 | 2020 | 5652 | 0.20 | Why? |
| Stress Disorders, Traumatic, Acute | 1 | 2021 | 141 | 0.19 | Why? |
| Hormone Replacement Therapy | 1 | 2020 | 146 | 0.19 | Why? |
| Lower Extremity | 2 | 2021 | 593 | 0.19 | Why? |
| Lung Volume Measurements | 1 | 2018 | 115 | 0.18 | Why? |
| Influenza A Virus, H1N1 Subtype | 3 | 2017 | 2984 | 0.18 | Why? |
| Herpesvirus 4, Human | 1 | 2020 | 387 | 0.17 | Why? |
| Echocardiography, Doppler | 1 | 2019 | 269 | 0.17 | Why? |
| Betacoronavirus | 11 | 2020 | 204454 | 0.17 | Why? |
| Olfactory Bulb | 1 | 2020 | 333 | 0.17 | Why? |
| Expert Testimony | 1 | 2020 | 658 | 0.16 | Why? |
| Macrophages, Alveolar | 1 | 2020 | 668 | 0.16 | Why? |
| Epstein-Barr Virus Infections | 1 | 2020 | 366 | 0.16 | Why? |
| Patients' Rooms | 1 | 2021 | 675 | 0.16 | Why? |
| Microscopic Polyangiitis | 1 | 2015 | 31 | 0.15 | Why? |
| Ventricular Function, Right | 1 | 2019 | 388 | 0.15 | Why? |
| Humans | 47 | 2021 | 930598 | 0.15 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.15 | Why? |
| Venous Thrombosis | 2 | 2021 | 2739 | 0.15 | Why? |
| Immunocompetence | 1 | 2017 | 280 | 0.15 | Why? |
| Catheterization, Central Venous | 1 | 2020 | 458 | 0.14 | Why? |
| Churg-Strauss Syndrome | 1 | 2015 | 61 | 0.14 | Why? |
| Manikins | 1 | 2017 | 466 | 0.14 | Why? |
| Interleukin-8 | 1 | 2020 | 964 | 0.14 | Why? |
| Clinical Laboratory Techniques | 3 | 2020 | 23402 | 0.14 | Why? |
| Fibrinogen | 1 | 2020 | 1048 | 0.13 | Why? |
| Intubation, Intratracheal | 2 | 2021 | 3962 | 0.13 | Why? |
| Administration, Inhalation | 1 | 2020 | 1647 | 0.13 | Why? |
| Ultrasonography, Interventional | 1 | 2019 | 560 | 0.13 | Why? |
| Trachea | 1 | 2019 | 894 | 0.13 | Why? |
| Leukocytes | 1 | 2020 | 1046 | 0.13 | Why? |
| Shock, Cardiogenic | 1 | 2020 | 700 | 0.13 | Why? |
| Granulomatosis with Polyangiitis | 1 | 2015 | 161 | 0.12 | Why? |
| Continuous Positive Airway Pressure | 1 | 2021 | 1187 | 0.12 | Why? |
| Diagnosis, Differential | 2 | 2017 | 7220 | 0.12 | Why? |
| Hospitalization | 6 | 2021 | 54280 | 0.11 | Why? |
| Aged | 18 | 2021 | 215776 | 0.11 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2020 | 2309 | 0.11 | Why? |
| Female | 22 | 2021 | 380317 | 0.11 | Why? |
| Surgery Department, Hospital | 1 | 2021 | 954 | 0.11 | Why? |
| Acute Disease | 3 | 2021 | 6029 | 0.11 | Why? |
| Middle Aged | 19 | 2021 | 270681 | 0.11 | Why? |
| Endovascular Procedures | 1 | 2020 | 1302 | 0.11 | Why? |
| Male | 23 | 2021 | 367725 | 0.10 | Why? |
| Precision Medicine | 1 | 2020 | 1477 | 0.10 | Why? |
| Heart | 1 | 2020 | 1791 | 0.10 | Why? |
| Orthomyxoviridae Infections | 1 | 2017 | 1001 | 0.10 | Why? |
| Respiration, Artificial | 5 | 2020 | 22116 | 0.10 | Why? |
| Thrombosis | 2 | 2021 | 7504 | 0.09 | Why? |
| Adult | 15 | 2021 | 244371 | 0.09 | Why? |
| Noninvasive Ventilation | 1 | 2021 | 2329 | 0.09 | Why? |
| Critical Illness | 3 | 2020 | 17281 | 0.09 | Why? |
| Internationality | 1 | 2020 | 3297 | 0.09 | Why? |
| Simulation Training | 1 | 2017 | 957 | 0.09 | Why? |
| Thrombocytopenia | 1 | 2021 | 2093 | 0.09 | Why? |
| Pandemics | 18 | 2021 | 389249 | 0.08 | Why? |
| Point-of-Care Systems | 1 | 2020 | 2955 | 0.08 | Why? |
| Anesthesiology | 1 | 2017 | 1163 | 0.08 | Why? |
| Influenza A virus | 1 | 2019 | 2234 | 0.08 | Why? |
| Body Mass Index | 1 | 2020 | 4306 | 0.08 | Why? |
| Endoscopy | 1 | 2017 | 1564 | 0.08 | Why? |
| Tomography, X-Ray Computed | 3 | 2018 | 25144 | 0.08 | Why? |
| Hypoxia | 1 | 2021 | 3626 | 0.08 | Why? |
| Consensus | 1 | 2020 | 6345 | 0.08 | Why? |
| Genetic Predisposition to Disease | 1 | 2020 | 4027 | 0.07 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 3633 | 0.07 | Why? |
| Viral Load | 3 | 2020 | 15850 | 0.07 | Why? |
| Influenza, Human | 3 | 2019 | 10779 | 0.07 | Why? |
| Stress Disorders, Post-Traumatic | 1 | 2021 | 2963 | 0.07 | Why? |
| Electrocardiography | 1 | 2019 | 3957 | 0.07 | Why? |
| Respiratory System | 1 | 2017 | 3213 | 0.07 | Why? |
| Myocarditis | 1 | 2020 | 2731 | 0.07 | Why? |
| C-Reactive Protein | 1 | 2020 | 7972 | 0.06 | Why? |
| Heart Diseases | 1 | 2020 | 3503 | 0.06 | Why? |
| Radiography, Thoracic | 1 | 2020 | 5486 | 0.06 | Why? |
| Computer Simulation | 1 | 2017 | 4982 | 0.06 | Why? |
| Hospital Mortality | 3 | 2021 | 22087 | 0.06 | Why? |
| Interleukin-6 | 1 | 2020 | 7522 | 0.06 | Why? |
| Immunoglobulin M | 1 | 2020 | 9091 | 0.06 | Why? |
| Patient Admission | 1 | 2019 | 5250 | 0.06 | Why? |
| Virion | 2 | 2020 | 1444 | 0.06 | Why? |
| Anticoagulants | 2 | 2021 | 9563 | 0.06 | Why? |
| Inclusion Bodies, Viral | 1 | 2020 | 32 | 0.06 | Why? |
| Aged, 80 and over | 8 | 2021 | 88759 | 0.05 | Why? |
| Respiratory Tract Infections | 2 | 2019 | 6817 | 0.05 | Why? |
| Angiography | 1 | 2021 | 301 | 0.05 | Why? |
| Risk Assessment | 2 | 2020 | 25439 | 0.05 | Why? |
| Magnetic Resonance Imaging | 1 | 2016 | 6551 | 0.05 | Why? |
| Diastole | 1 | 2019 | 168 | 0.05 | Why? |
| Microscopy, Electron, Transmission | 1 | 2020 | 605 | 0.05 | Why? |
| Prevalence | 4 | 2021 | 25773 | 0.05 | Why? |
| Systole | 1 | 2019 | 252 | 0.05 | Why? |
| Amputation | 1 | 2021 | 331 | 0.04 | Why? |
| Inflammation | 1 | 2020 | 13255 | 0.04 | Why? |
| Prospective Studies | 5 | 2021 | 43301 | 0.04 | Why? |
| Ultrasonography, Doppler | 1 | 2021 | 406 | 0.04 | Why? |
| High Fidelity Simulation Training | 1 | 2017 | 44 | 0.04 | Why? |
| Statistics, Nonparametric | 1 | 2020 | 1008 | 0.04 | Why? |
| Chi-Square Distribution | 1 | 2020 | 961 | 0.04 | Why? |
| Bronchoalveolar Lavage | 1 | 2020 | 603 | 0.04 | Why? |
| Biomarkers | 1 | 2020 | 23361 | 0.04 | Why? |
| Internship and Residency | 1 | 2017 | 4987 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.04 | Why? |
| Reference Values | 1 | 2019 | 795 | 0.04 | Why? |
| Sus scrofa | 1 | 2017 | 205 | 0.04 | Why? |
| Immunoglobulin G | 1 | 2020 | 21571 | 0.04 | Why? |
| Cannula | 1 | 2021 | 750 | 0.04 | Why? |
| Practice Guidelines as Topic | 1 | 2020 | 15421 | 0.04 | Why? |
| Emergency Service, Hospital | 1 | 2020 | 14232 | 0.04 | Why? |
| Laryngostenosis | 1 | 2015 | 48 | 0.04 | Why? |
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2019 | 511 | 0.04 | Why? |
| Treatment Failure | 1 | 2021 | 2106 | 0.04 | Why? |
| Opportunistic Infections | 1 | 2020 | 602 | 0.03 | Why? |
| Retrospective Studies | 6 | 2021 | 105322 | 0.03 | Why? |
| Single-Blind Method | 1 | 2017 | 1283 | 0.03 | Why? |
| Interleukin-10 | 1 | 2020 | 1409 | 0.03 | Why? |
| Lymphocyte Subsets | 1 | 2020 | 987 | 0.03 | Why? |
| Knowledge | 1 | 2017 | 452 | 0.03 | Why? |
| Ventricular Dysfunction, Right | 1 | 2020 | 639 | 0.03 | Why? |
| Mesenteric Ischemia | 1 | 2015 | 128 | 0.03 | Why? |
| Antibodies, Neutralizing | 1 | 2020 | 25288 | 0.03 | Why? |
| Tertiary Care Centers | 2 | 2020 | 8248 | 0.03 | Why? |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2015 | 235 | 0.03 | Why? |
| History, 21st Century | 1 | 2019 | 1849 | 0.03 | Why? |
| Hospitals, Teaching | 1 | 2020 | 1609 | 0.03 | Why? |
| Europe | 2 | 2020 | 12702 | 0.03 | Why? |
| Molecular Sequence Data | 1 | 2017 | 3198 | 0.03 | Why? |
| Real-Time Polymerase Chain Reaction | 2 | 2020 | 11367 | 0.03 | Why? |
| Biopsy | 1 | 2020 | 2811 | 0.03 | Why? |
| Leukocytes, Mononuclear | 1 | 2020 | 2115 | 0.03 | Why? |
| Drug Combinations | 1 | 2020 | 3852 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Killer Cells, Natural | 1 | 2020 | 2093 | 0.03 | Why? |
| Antiviral Agents | 2 | 2020 | 41703 | 0.03 | Why? |
| DNA, Viral | 1 | 2020 | 2521 | 0.03 | Why? |
| Polymorphism, Genetic | 1 | 2017 | 1074 | 0.02 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2020 | 13720 | 0.02 | Why? |
| Phenotype | 1 | 2021 | 4037 | 0.02 | Why? |
| Educational Measurement | 1 | 2017 | 930 | 0.02 | Why? |
| Thrombectomy | 1 | 2021 | 2272 | 0.02 | Why? |
| Phylogeny | 2 | 2019 | 13341 | 0.02 | Why? |
| Base Sequence | 1 | 2017 | 3581 | 0.02 | Why? |
| Autopsy | 1 | 2020 | 3495 | 0.02 | Why? |
| Lymphocyte Count | 1 | 2020 | 4758 | 0.02 | Why? |
| Survivors | 1 | 2021 | 2619 | 0.02 | Why? |
| Treatment Outcome | 3 | 2021 | 51732 | 0.02 | Why? |
| Macrophages | 1 | 2020 | 2784 | 0.02 | Why? |
| Academic Medical Centers | 1 | 2020 | 3088 | 0.02 | Why? |
| Heparin | 1 | 2021 | 2600 | 0.02 | Why? |
| Myocardium | 1 | 2020 | 2323 | 0.02 | Why? |
| Sequence Analysis, DNA | 1 | 2017 | 2830 | 0.02 | Why? |
| Thromboembolism | 1 | 2020 | 2101 | 0.02 | Why? |
| Lymphocytes | 1 | 2020 | 3056 | 0.02 | Why? |
| Oxygen Inhalation Therapy | 1 | 2021 | 3629 | 0.02 | Why? |
| Prognosis | 2 | 2021 | 32490 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2020 | 51949 | 0.02 | Why? |
| Swine Diseases | 1 | 2017 | 1219 | 0.02 | Why? |
| Risk Factors | 3 | 2020 | 71621 | 0.02 | Why? |
| Time Factors | 2 | 2020 | 31397 | 0.02 | Why? |
| Blood Donors | 1 | 2020 | 2956 | 0.02 | Why? |
| Neutralization Tests | 1 | 2020 | 6698 | 0.02 | Why? |
| Seasons | 1 | 2019 | 4071 | 0.02 | Why? |
| Lopinavir | 1 | 2020 | 4308 | 0.02 | Why? |
| Survival Rate | 1 | 2020 | 9206 | 0.02 | Why? |
| Ritonavir | 1 | 2020 | 4212 | 0.02 | Why? |
| Public Health Surveillance | 1 | 2019 | 3129 | 0.02 | Why? |
| Young Adult | 3 | 2020 | 93724 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2020 | 10017 | 0.02 | Why? |
| Neutrophils | 1 | 2020 | 5476 | 0.02 | Why? |
| Immunization, Passive | 1 | 2020 | 10067 | 0.02 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2020 | 5837 | 0.02 | Why? |
| Adolescent | 3 | 2020 | 86841 | 0.02 | Why? |
| Mortality | 1 | 2020 | 7132 | 0.02 | Why? |
| Adrenal Cortex Hormones | 1 | 2020 | 6537 | 0.02 | Why? |
| Bacterial Infections | 1 | 2017 | 2229 | 0.02 | Why? |
| Adenosine Monophosphate | 1 | 2020 | 5652 | 0.02 | Why? |
| Alanine | 1 | 2020 | 5687 | 0.02 | Why? |
| Hemorrhage | 1 | 2015 | 3013 | 0.02 | Why? |
| Brain | 1 | 2020 | 5133 | 0.02 | Why? |
| Clinical Competence | 1 | 2017 | 3263 | 0.02 | Why? |
| Olfaction Disorders | 1 | 2020 | 3704 | 0.01 | Why? |
| Postoperative Complications | 1 | 2021 | 5861 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2020 | 17020 | 0.01 | Why? |
| Longitudinal Studies | 1 | 2017 | 9893 | 0.01 | Why? |
| Triage | 1 | 2020 | 7151 | 0.01 | Why? |
| Lung Diseases | 1 | 2015 | 2361 | 0.01 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 9335 | 0.01 | Why? |
| Age Factors | 1 | 2019 | 21039 | 0.01 | Why? |
| Infant, Newborn | 1 | 2019 | 23105 | 0.01 | Why? |
| Disease Transmission, Infectious | 1 | 2020 | 9044 | 0.01 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.01 | Why? |
| Infant | 1 | 2019 | 30274 | 0.01 | Why? |
| Child, Preschool | 1 | 2019 | 36283 | 0.01 | Why? |
| Anti-Bacterial Agents | 1 | 2017 | 10083 | 0.01 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.01 | Why? |
| China | 1 | 2020 | 50654 | 0.01 | Why? |
| Cohort Studies | 1 | 2015 | 36005 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2020 | 37182 | 0.01 | Why? |
| Child | 1 | 2019 | 70012 | 0.01 | Why? |
| Animals | 1 | 2017 | 78931 | 0.01 | Why? |